SII Launches HPV Vaccine

September 02, 2022
Current Context: The Serum Institute of India (SII) and the Department of Biotechnology (DBT) launched the first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine, CERVAVAC for the prevention of cervical cancer.
SII Launches HPV Vaccine
  • It will be the first Quadrivalent Human Papilloma Virus vaccine (qHPV) in India, to prevent cervical cancer.
  • The HPV vaccine protects against the types of HPV that most often cause vulvar, cervical, and vaginal cancers.
  • For 9-14 year-olds, the vaccine will be in two doses & for 15-26 year-olds it will be a three-dose schedule.
  • Cervical cancer starts in the cervix and according to the Centers for Disease Control and Prevention (CDCP), all women are at risk for cervical cancer.
  • According to the World Health Organization (WHO) data, more than 4 million women have died due to cervical cancer in India since 2019.
  • Serum Institute of India was founded by Dr. Cyrus Poonawalla in 1966 and has headquarters in Pune, Maharashtra.

Question:

Q.1 Human Papilloma Virus causes which disease?
a. Leukemia
b. AIDS
c. Hepatitis-B
d. Cervical Cancer

Free Exam Resources

Useful material to support your preparation, revision and exam planning.

Continue on BankExamsToday

Revise notes, practice questions and resume anytime.

Meet your mentor

From the Founder

Ramandeep Singh, founder of BankExamsToday

Ramandeep Singh

Banking Educator · Former Banker

Former banker and educator helping aspirants prepare for banking promotion and specialist officer exams with focused, practical guidance.

14+
Years' experience
5,000+
Selections
Ex-BoB
Banking experience